These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2681561)

  • 1. Growth curve patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris submitted to different tigemonam concentrations.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F
    J Chemother; 1989 May; 1 Suppl 2():49-53. PubMed ID: 2681561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth Curve Patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris Submitted to Different Tigemonam Concentrations.
    Yourassowsky E; Linden MP; Lismont MJ; Crokaert F
    J Chemother; 1989 May; 1(sup2):49-53. PubMed ID: 27416151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of tigemonam against multiresistant nosocomial Enterobacteriaceae.
    Giamarellou H; Pephanis A; Grammatikou M; Avlamis A; Papoulias G
    J Chemother; 1989 May; 1 Suppl 2():32-5. PubMed ID: 2809700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity in vitro of tigemonam, a new oral monobactam.
    Schito GC; Debbia E; Bandelloni R; Paglia P; Pesce A
    J Chemother; 1989 May; 1 Suppl 2():41-4. PubMed ID: 2809702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity of tigemonam, alone and in combination with gentamicin.
    Shah PM; Gänger-Farshid G; Mulert R; Stille W
    J Chemother; 1989 May; 1 Suppl 2():45-8. PubMed ID: 2809703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity of tigemonam dicholate (SQ 30836) and interaction with beta-lactamases of gram-negative bacteria.
    Raimondi A; Cocuzza CE
    J Chemother; 1989 May; 1 Suppl 2():13-21. PubMed ID: 2809698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of tigemonam against urinary tract pathogens.
    Garcia-Rodriguez JA; Garcia-Sanchez JE
    J Chemother; 1989 May; 1 Suppl 2():28-31. PubMed ID: 2809699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies of tigemonam: a comparison of the minimum inhibitory and minimum bactericidal concentrations (MIC vs MBC).
    Gobernado M; Cantón E
    J Chemother; 1989 May; 1 Suppl 2():36-40. PubMed ID: 2809701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigemonam, an oral monobactam.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1988 Jan; 32(1):84-91. PubMed ID: 3279906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antimicrobial activity of tigemonam, a new orally administered monobactam.
    Fuchs PC; Jones RN; Barry AL
    Antimicrob Agents Chemother; 1988 Mar; 32(3):346-9. PubMed ID: 3259122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
    Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in-vitro activity of tigemonam, a new monobactam.
    Rylander M; Gezelius L; Norrby SR
    J Antimicrob Chemother; 1988 Sep; 22(3):307-13. PubMed ID: 3182428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
    Burgess DS; Summers KK; Hardin TC
    Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacterial combination effect between carumonam and eight other antibiotics].
    Obana Y; Murakami T; Kuzui H; Nishino T
    Jpn J Antibiot; 1990 Dec; 43(12):2094-101. PubMed ID: 2128341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination antibacterial effects between aztreonam and eight other antibiotics].
    Nishino T; Obana Y; Kuzui H; Murakami T
    Jpn J Antibiot; 1991 Jan; 44(1):1-8. PubMed ID: 1904106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The kinetics of bacterial killing by fluctuating concentrations of antibiotics].
    Guggenbichler JP; Allerberger F; Bonatti H; Semenitz E; Dierich MP
    Wien Klin Wochenschr; 1989 Mar; 101(7):224-9. PubMed ID: 2652890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bactericidal and morphological effects of five cephamycins on cells of three gram-negative bacilli at decreasing drug concentrations.
    Goi H; Watanabe T; Miyauchi K; Kazuno Y; Inouye S
    Drugs Exp Clin Res; 1985; 11(11):771-80. PubMed ID: 3915467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gentamicin susceptibility of gram-negative problem germs and staphylococci, indicated by the tube dilution method].
    Modde H
    Pathol Microbiol (Basel); 1972; 38(4):286-95. PubMed ID: 4565703
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibacterial Activity of Tigemonam Dicholate (SQ 30836) and Interaction With Beta-Lactamases of Gram-Negative Bacteria.
    Raimondi A; Cocuzza CE
    J Chemother; 1989 May; 1(sup2):13-21. PubMed ID: 27416144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tigemonam activity against clinical isolates of Enterobacteriaceae and Enterobacteriaceae with known mechanisms of resistance to beta-lactam antibiotics.
    Nélet F; Gutmann L; Kitzis MD; Acar JF
    J Antimicrob Chemother; 1989 Aug; 24(2):173-81. PubMed ID: 2676940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.